These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20084193)

  • 1. High defibrillation threshold: the science, signs and solutions.
    Jacob S; Pidlaoan V; Singh J; Bharadwaj A; Patel MB; Carrillo A
    Indian Pacing Electrophysiol J; 2010 Jan; 10(1):21-39. PubMed ID: 20084193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing.
    Duffett S; El Hajjaji I; Manlucu J; Yee R
    Card Electrophysiol Clin; 2018 Mar; 10(1):119-125. PubMed ID: 29428133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High defibrillation threshold with right-sided ICD implantation was resolved by a dual coil lead via persistent left superior vena cava.
    Fujito T; Nagahara D; Tsuzuki T; Kamiyama N; Mochizuki A; Miura T
    J Cardiol Cases; 2022 May; 25(5):262-265. PubMed ID: 35582083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defibrillation threshold testing during implantable cardioverter defibrillator implantation: 5-year follow-up.
    Kim SS; Park HW; Jeong HK; Lee KH; Yoon NS; Cho JG
    J Interv Card Electrophysiol; 2021 Apr; 60(3):485-491. PubMed ID: 32399866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
    Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
    Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
    van der Stuijt W; Quast ABE; Knops RE
    Neth Heart J; 2020 Aug; 28(Suppl 1):122-127. PubMed ID: 32780342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vein defibrillator coil placement in patients with high defibrillation thresholds.
    Rodríguez-Mañero M; Kreidieh B; Ibarra-Cortez SH; Álvarez P; Schurmann P; Dave AS; Valderrábano M
    J Arrhythm; 2019 Feb; 35(1):79-85. PubMed ID: 30805047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans.
    Neuzil P; Reddy VY; Merkely B; Geller L; Molnar L; Bednarek J; Bartus K; Richey M; Bsee TJ; Sanders WE
    Heart Rhythm; 2014 Feb; 11(2):210-5. PubMed ID: 24144885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II.
    Gradaus R; Block M; Seidl K; Brunn J; Isgro F; Hammel D; Hauer B; Breithardt G; Bocker D
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):921-7. PubMed ID: 11513444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator].
    Jung J; Neuzner J; Himmrich E; Vester E; Michel U; Fries R; Pitschner H; Liebrich A; Ganschow U; Heisel A
    Z Kardiol; 1998 Dec; 87(12):971-7. PubMed ID: 10025070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrillation threshold in elective subcutaneous implantable defibrillator generator replacements: Time to reduce the size of the pulse generator?
    van der Stuijt W; Pepplinkhuizen S; de Veld JA; Quast ABE; van Halm VP; Bijsterveld NR; Olde Nordkamp LRA; Wilde AAM; Smeding L; Knops RE
    Int J Cardiol; 2024 Mar; 398():131639. PubMed ID: 38065323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management.
    Shehadeh M; Brar V; Costello J; Hadadi C; O'Donoghue S; Worley S
    Heart Rhythm O2; 2020 Dec; 1(5):336-340. PubMed ID: 34113891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?
    Russo AM; Sauer W; Gerstenfeld EP; Hsia HH; Lin D; Cooper JM; Dixit S; Verdino RJ; Nayak HM; Callans DJ; Patel V; Marchlinski FE
    Heart Rhythm; 2005 May; 2(5):456-61. PubMed ID: 15840466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E; Liebrich A; Michel U; Neuzner J; Pitschner H; Heisel A; Vester E; Ganschov U; Jung J
    Z Kardiol; 1999 Feb; 88(2):103-12. PubMed ID: 10209831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implantable cardioverter/defibrillator: long-term stability of the defibrillation threshold with a unipolar electrode configuration (active-can")].
    Knuefermann P; Wolpert C; Spehl S; Korte T; Manz M; Lüderitz B; Jung W
    Z Kardiol; 2000 Sep; 89(9):774-80. PubMed ID: 11077687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation.
    Verma A; Kaplan AJ; Sarak B; Oosthuizen R; Beardsall M; Higgenbottam J; Wulffhart Z; Khaykin Y
    J Interv Card Electrophysiol; 2010 Nov; 29(2):127-33. PubMed ID: 20865309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM; Wang Y; Al-Khatib SM; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2013 Dec; 36(12):1522-31. PubMed ID: 23981009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.